800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| Kahmien A. LaRusch, M.D. | 2340 Paseo del Prado Suite D – 207 | Las Vegas |
| WestCare Nevada Inc – Las Vegas Community Involvement Center | 323 North Maryland Parkway | Las Vegas |
| Las Vegas Comprehensive Treatment Center | 2887 South Maryland Parkway | Las Vegas |
| Desert Hope Outpatient | 3441 S Eastern Ave | Las Vegas |
| US VETS – Las Vegas | 525 East Bonanza Road | Las Vegas |
| Landmark Recovery of Las Vegas | 3371 N Buffalo Dr | Las Vegas |
| Center for Behavioral Health – Desert Inn | 3050 E Desert Inn Rd APT 116 | Las Vegas |
| Vegas Valley Treatment Center Inc | 1325 South Commerce Street | Las Vegas |
| Dr. Festus – Nevada Care & Treatment Center | 1721 East Charleston Boulevard | Las Vegas |
| Recovery Institute of Nevada | 1771 E Flamingo Rd Suite 112B | Las Vegas |
| Center for Behavioral Health – Las Vegas | 1311 S Casino Center Blvd | Las Vegas |
| New Beginnings Counseling and Methadone Clinic | 3675 Pecos McLeod Interconnect Ste 700 | Las Vegas |
| Methadone Treatment Drug Rehab Centers In Las Vegas, Nevada, United States | 3371 North Buffalo Drive | Las Vegas |
| Karen L. Cruey, M.D. | 2340 Paseo del Prado D207 | Las Vegas |
| New Beginnings Counseling Centers | 3675 Pecos McLeod Suite 900 | Las Vegas |
| The Adelson Clinic | 3661 South Maryland Parkway Suite 64 | Las Vegas |
| Guadalupe Medical Center | Guadalupe Medical Center 1219 East Charleston Boulevard | Las Vegas |
| Center for Behavioral Health – McDaniel | 2290 McDaniel Street Suite 1C | North Las Vegas |
| Henderson Comprehensive Treatment Center | 1536 N Boulder Hwy | Henderson |
| Desert Treatment Clinic | 1546 West Warm Springs Road Suite 130 | Henderson |
No results found!
Medication treatment for opioid use disorder in Las Vegas
Las Vegas and the surrounding Clark County are served by both opioid treatment programs and office-based prescribers, which means most people here can reach more than one kind of medication care without leaving the valley. The three medications approved for opioid use disorder (OUD) are methadone, buprenorphine (including Suboxone), and naltrexone (including the Vivitrol injection), and they are offered across daily-dosing clinics and regular doctors’ offices. The provider listings on this page show local options; the helpline can connect you with someone now. Below, you will find how each medication and setting works in Las Vegas, what it costs, and where to start.
Your treatment options and where to get them in the valley
Opioid use disorder is treated with three FDA-approved medications, and where you get each one differs. Methadone for OUD is dispensed only through a federally certified opioid treatment program (OTP), not a regular pharmacy, so you visit the clinic to receive your dose, with take-home doses added as you stabilize. Buprenorphine, including Suboxone and buprenorphine-naloxone, can be prescribed in a doctor’s office by any clinician with a standard DEA registration and filled at a pharmacy, and it is also offered inside OTPs. Extended-release injectable buprenorphine (Sublocade) is given as a monthly shot. Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and any licensed provider can prescribe it, though it is started only after you have been off opioids for a set time.
That split between settings matters in a metro this size. An opioid treatment program offers structure and on-site methadone or buprenorphine, while office-based opioid treatment (OBOT) lets you see a primary care or addiction provider and pick up buprenorphine or naltrexone at the pharmacy. If you are weighing the choice, it helps to read how methadone and Suboxone compare and what daily life looks like on each before you call. There is no single right answer; you and a clinician decide together based on your history and your schedule.
Starting treatment: what the first visit looks like
The first step is an intake and assessment, where a provider reviews your history, confirms a diagnosis, and starts you on medication, often the same day at programs that offer it. If you are using fentanyl, timing matters: starting buprenorphine too soon after fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans when to take that first dose, sometimes using a low-dose start. Methadone does not carry that same timing risk and can be started while you still have opioids in your system. Bring an ID and any insurance information if you have them, but not having them should not stop you from calling. For more on starting medication after fentanyl, see our guide on methadone treatment for fentanyl addiction and the broader overview of opioid addiction treatment.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 (the revision of 42 CFR Part 8) expanded take-home methadone, up to a 28-day supply for patients who are stable in treatment, with take-home eligibility decided by the program. The same update lets treatment start by telehealth and removed the old requirement that someone have a year of opioid use before being admitted. For buprenorphine, telehealth flexibilities current as of June 2026 allow treatment to begin through a video visit, and by phone in many cases, without a prior in-person appointment; those rules run through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for OUD remains dispensed through an OTP even when the first visit happens by telehealth. If you are transferring from another clinic or returning after a break, ask about guest dosing and how take-homes carry over, and read why staying consistent with your dose matters during a move.
Paying for treatment
Nevada Medicaid covers all three medications for opioid use disorder, including methadone dispensed through opioid treatment programs, buprenorphine products, and the Vivitrol injection, though some products require prior authorization. As of January 1, 2026, Nevada Medicaid moved to a Single Preferred Drug List across its fee-for-service and managed care plans (Anthem, Health Plan of Nevada, and SilverSummit), with a transition period running through June 30, 2026 so current prescriptions are not interrupted. Private insurance and Medicare also cover MOUD, and many programs offer self-pay or sliding-scale fees. Cost is often the first worry, so ask each provider directly what they accept; the listings on this page and the helpline can help you sort this out before your first visit.
The overdose picture in Clark County, and what is being done
Fentanyl has driven overdose deaths in Clark County, but the most recent data shows a turn. Fentanyl-involved deaths rose for six straight years and peaked at 454 in 2024, then fell to 403 in 2025 (Southern Nevada Health District, healthysouthernnevada.org, 2026). Opioid overdose deaths dropped about 20 percent from August 2024 to August 2025 (Southern Nevada Health District, 2026). Officials credit part of that decline to a large expansion of naloxone: the Health District distributed 212,112 doses in 2025, up from 85,502 in 2024. The takeaway is not that the danger has passed but that treatment and overdose-reversal tools are reaching people and that effective medication care is available right here. If you want to understand the condition behind these numbers, our overview of opioid addiction is a place to start.
Naloxone and overdose prevention in Las Vegas
Naloxone, the medication that reverses an opioid overdose, is widely available in Las Vegas. Nevada’s Good Samaritan Drug Overdose Act (NRS 453C) lets pharmacists provide naloxone without an individual prescription and shields people who call 911 for an overdose from certain drug-possession charges, and an over-the-counter version of Narcan is sold at pharmacies. The Southern Nevada Health District offers free naloxone and fentanyl and xylazine test strips at its public health centers and through its Substance Use Dashboard, runs a mail-order test-strip program, and partners with Foundation for Recovery on door-to-door outreach in neighborhoods with higher overdose rates. The Southern Nevada Post Overdose Response Team (SPORT) follows up with people after an overdose. If you or someone you love uses opioids, carrying naloxone is a reasonable safety step, and a return to use is a common, manageable part of treating a chronic condition rather than a failure. You can learn the warning signs of an opioid overdose and how to respond.
Pregnancy, parenting, and justice-involved care
Some situations call for treatment built around them. For pregnant and postpartum people, medication treatment with methadone or buprenorphine is the recommended standard of care, and Nevada’s EMPOWERED Program serves the Southern Nevada region with care plans, counseling, and peer support for pregnant and parenting people who use opioids or stimulants. Pregnant patients receive priority admission at treatment facilities funded by the state’s block grant. Nevada uses a CARA Plan of Care to connect a newborn affected by prenatal substance exposure and the parent to services; it is a voluntary support referral and is kept separate from a child-protective safety assessment, which matters if fear of losing custody has kept you from seeking care. Treatment is the protective step, not a risk to hide. For people leaving the Clark County jail system or under court supervision, ask a provider about coordinating intake and any documentation a court or probation officer requires. Families helping someone navigate this can start with our guidance for families and information on methadone and pregnancy.
Common questions about treatment in Las Vegas
Is methadone or Suboxone better?
Neither is better for everyone. Methadone is a full agonist taken daily, available only through an opioid treatment program, and is often chosen for higher tolerance, including after fentanyl. Buprenorphine (Suboxone) is a partial agonist with a ceiling effect that lowers overdose risk and can be prescribed in an office and filled at a pharmacy. The right fit depends on your history and needs, which you decide with a clinician.
Do I have to go to a clinic every day?
Not necessarily. Methadone starts with in-clinic dosing, but federal rules now allow up to a 28-day take-home supply for patients who are stable, decided by the program. Buprenorphine and naltrexone prescribed in an office are filled at a pharmacy, so they do not require daily clinic visits.
Can I start treatment the same day?
Some Las Vegas providers offer same-day or next-day intake, and federal rules allow treatment to begin by telehealth in many cases. Availability varies by provider, so call the options on this page or the helpline to ask about the soonest appointment.
Will my insurance cover it?
Nevada Medicaid covers all three OUD medications, and private insurance and Medicare also cover treatment. Some medications need prior authorization. Ask each provider what they accept and whether they offer sliding-scale or self-pay options.
Can buprenorphine be started by telehealth in Nevada?
As of June 2026, yes in many cases, including by phone, without a prior in-person visit under flexibilities that run through the end of 2026. These rules are still being finalized, so confirm current options with a provider. Methadone for OUD is still dispensed through an opioid treatment program.
How this page is maintained
Last reviewed June 2026.
Sources:
- Southern Nevada Health District, Substance Use Dashboard and overdose data (healthysouthernnevada.org), 2026.
- Southern Nevada Health District, naloxone distribution and Save a Life Day (southernnevadahealthdistrict.org), 2025 and 2026.
- Nevada Division of Health Care Financing and Policy, Medicaid-covered drugs for opioid addiction (dhcfp.nv.gov).
- Nevada Medicaid, Single Preferred Drug List transition (medicaid.nv.gov), December 2025.
- Nevada Revised Statutes Chapter 453C, Good Samaritan Drug Overdose Act (leg.state.nv.us).
- Nevada Division of Public and Behavioral Health, Perinatal Substance Use Treatment Network and CARA Plan of Care (dpbh.nv.gov).
- SAMHSA and DEA, 42 CFR Part 8 (2024) and buprenorphine telemedicine rules, 2024 to 2026.
Methadone Centers is a treatment-discovery and education resource, not a medical provider. The information here is educational and is not medical advice; treatment decisions should be made with a licensed clinician.
Calls placed through the helpline on this page may be answered by a sponsored treatment provider. Using this site does not guarantee admission to any specific program.